In a strategic move, Medicana Health Group is extending its realm of exceptional healthcare services to the UK, aiming to address the escalating demand for premier healthcare.
Renowned for its holistic healthcare solutions, Medicana Health Group is poised to make a significant impact on the UK healthcare scene by bringing its signature patient-centric care and customised treatment plans. This initiative is a proactive response to the growing preference for private healthcare and insurance solutions in the aftermath of the COVID crisis. Anchored by a dedication to “active listening and personalised attention,” Medicana pledges to fully comprehend and meet each patient’s unique needs, ensuring a bespoke healthcare pathway from the initial consultation to aftercare, thereby aspiring to redefine private healthcare excellence in the UK.
Through its commitment to “active listening and personalised attention at every stage of the patient’s journey,” Medicana Health Group promises an exceptionally personalised and thoughtfully planned patient experience, replicating their successful approach in Türkiye to set a new standard in the UK’s private healthcare domain.
Penetrating the £282 Billion UK Healthcare Market
The resurgence of the UK’s private healthcare sector in the years following the COVID-19 pandemic has been notably propelled by a rise in individuals opting to pay for their healthcare. An unprecedented number of people are now turning to private healthcare to sidestep the NHS’s extended waiting lists and to access the superior care and expertise of the independent sector. The Akeso report estimates the total healthcare expenditure in the UK for the year 2022 to be around £282 billion, with public spending making up roughly 80% and private outlays about 20%.
Capitalising on this market potential, Medicana is set to apply its deep-seated expertise and broad spectrum of care services to break into the UK’s private healthcare sector. By rolling out its tested healthcare model, which includes a full suite of services from leading-edge diagnostics to tailor-made treatments, Medicana is well-prepared to satisfy the increasing demand for high-quality private healthcare. The group’s unwavering commitment to healthcare excellence, combined with its innovative approach to patient treatment, earmarks Medicana as an optimal solution to the UK’s healthcare challenges.
Catering to Over 5.5 Million Patients Yearly
Annually, Medicana Health Group provides superior healthcare to more than 5.5 million patients across the globe, supported by its network of 16 hospitals that boast significant bed capacities. This demonstrates their broad experience in delivering premier healthcare and their capability to meet the diverse healthcare needs of an international patient base. Medicana Health Group’s venture into the UK market is expected to drive a substantial move towards more compassionate, effective, and customised healthcare solutions, marking a pivotal moment in their dedication to enhancing patient welfare and global healthcare standards.
With a rich history exceeding 30 years, Medicana’s medical acumen spans a wide range of specialties, providing top-tier services in fields such as Oncology, Surgical Oncology, Organ and Bone Marrow Transplantation, Neurosurgery, In Vitro Fertilisation (IVF), Genetics, Cardiovascular Surgery, Orthopaedics and Traumatology, and Obesity Surgery. Since 2016, Medicana Health Group has also ventured into the educational sector, offering a broad array of educational programs from preschool to university level, both within Türkiye and internationally.